一些多化合物作为宫癌的潜在治疗剂:最近的进展和未来的前景
Nazlı Tunca Sanlier1, Koray Görkem Saçinti2,3, İnci Türkoğlu4
1Department of Obstetrics and Gynecology, Turkish Ministry of Health, Ankara City Hospital, Ankara 06800, Turkey.
Nutrition reviews
|September 16, 2024
概括
聚醇是食物中发现的天然化合物,通过调节细胞机制,在癌症治疗中表现有前途. 研究表明它们的安全性和影响宫癌发病率和管理的潜力.
科学领域:
- 在瘤学瘤学.
- 营养科学 营养科学
- 分子生物学分子生物学
背景情况:
- 癌症的发展涉及遗传和细胞通路的破坏.
- 来自饮食来源的多醇具有抗癌性质.
- 研究正在探索多在癌症化学预防和治疗中的作用.
研究的目的:
- 审查多的特性和抗癌机制.
- 检查多在宫癌管理中的潜力.
- 为进一步研究多在宫癌中的应用奠定基础.
主要方法:
- 关于多的特性和活性研究的文献综述.
- 在细胞过程中分析多的分子机制.
- 检查来自动物,细胞和人类研究的数据.
主要成果:
- 聚醇会影响炎症,细胞增殖,细胞亡和表观遗传变化.
- 有证据表明,多是安全的,耐受性很好.
- 多显示出改善癌症生物标志物的潜力.
结论:
- 多因其安全性,成本效益和可访问性而具有癌症治疗的巨大潜力.
- 进一步调查多在宫癌中的作用是有必要的.
- 聚可能在癌症治疗中提供一种有价值的补充方法.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Positive Regulator Molecules
5.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.4K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


